Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 86
Average round size
The average size of a deal this fund participated in
Portfolio companies 76
Rounds per year 6.14
Lead investments 14
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 11
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Artificial Intelligence
  • Manufacturing
  • Medical

In 2008 was created CPE, which is appeared as VC. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Beijing.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the CPE, startups are often financed by IDG Capital, GSR Ventures, DST Global. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, IDG Capital, Didi Chuxing. In the next rounds fund is usually obtained by Alibaba Group, IDG Capital, Beijing Hualian Group.

The usual things for fund are deals in the range of more than 100 millions dollars. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this CPE works on 2 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2018. When the investment is from CPE the average startup value is more than 1 billion dollars.

The overall number of key employees were 2.

Among the various public portfolio startups of the fund, we may underline Ele.me, JD Health, VANCL We can highlight the next thriving fund investment areas, such as Insurance, Internet. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CPE:
Typical Co-investors
CPE is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CPE:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Reliable Med

Medical Device
$15M01 Apr 2022 Hangzhou, Zhejiang, China


3D Technology
Information Technology
Operating Systems
$120M11 Mar 2022 Shenzhen, Guangdong, China


Artificial Intelligence
Health Care
Medical Device
$126M21 Jan 2022 Shenzhen, Guangdong, China

Lumous Intelligence

22 Dec 2021 -

Chipone Technology

Product Design
$1B15 Dec 2021 Beijing, Beijing, China


Health Care
Health Diagnostics
$46M30 Nov 2021 Hangzhou, Zhejiang, China

Hesai Technology

Autonomous Vehicles
$70M17 Nov 2021 Shanghai, China

Sepax Technologies

$77M15 Nov 2021 Delaware, Ohio, United States

Zhihe Technology

Internet of Things
12 Nov 2021 Jiangning, Jiangsu, China
Triastek Closes US$50M Series B Financing

– Triastek, Inc. is a Nanjing, China-based global leader in 3D printed pharmaceuticals.
– The company raised $50m in Series B funding.
– This round was co-led by Matrix Partners China and CPE with participation from Shanghai Sci-Tech Innovation Center Capital (SSICC) and existing investors.
– Triastek intends to use the funds for ongoing development of the first IND-approved product in clinical trials, and expansion of the 3D printed drug product pipeline.

Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus

– Insilico Medicine announced that it has closed a $255m Series C.
– The financing led by Warburg Pincus, and participated by current investors including Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ventures, Baidu Ventures, and new investors including CPE, OrbiMed, Mirae Asset Capital, B Capital Group, Deerfield Management, Maison Capital, Lake Bleu Capital, President International Development Corporation, Sequoia Capital China and Sage Partners.
– The financing will be used to progress Insilico Medicine’s current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CPE?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: